Structural Nested Models and G-estimation: The Partially Realized
  Promise by Vansteelandt, Stijn & Joffe, Marshall
ar
X
iv
:1
50
3.
01
58
9v
1 
 [s
tat
.M
E]
  5
 M
ar 
20
15
Statistical Science
2014, Vol. 29, No. 4, 707–731
DOI: 10.1214/14-STS493
c© Institute of Mathematical Statistics, 2014
Structural Nested Models and
G-estimation: The Partially Realized
Promise
Stijn Vansteelandt and Marshall Joffe
Abstract. Structural nested models (SNMs) and the associated method
of G-estimation were first proposed by James Robins over two decades
ago as approaches to modeling and estimating the joint effects of a se-
quence of treatments or exposures. The models and estimation methods
have since been extended to dealing with a broader series of problems,
and have considerable advantages over the other methods developed for
estimating such joint effects. Despite these advantages, the application
of these methods in applied research has been relatively infrequent; we
view this as unfortunate. To remedy this, we provide an overview of
the models and estimation methods as developed, primarily by Robins,
over the years. We provide insight into their advantages over other
methods, and consider some possible reasons for failure of the meth-
ods to be more broadly adopted, as well as possible remedies. Finally,
we consider several extensions of the standard models and estimation
methods.
Key words and phrases: Causal effect, confounding, direct effect, in-
strumental variable, mediation, time-varying confounding.
1. INTRODUCTION
Structural nested models (SNMs) were designed
in part to deal with confounding by variables af-
fected by treatment (Robins (1986)). The problem
arises when one is interested in estimating the joint
effect of a sequence of treatments in the presence of
a variable L with three characteristics, depicted in
Figure 1:
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1. It is independently associated with the outcome
Y of interest. This can happen because (a) it is
a direct cause of the outcome, or because (b) it
shares unmeasured common causes with the out-
come of interest.
2. It predicts subsequent levels (A1) of the treat-
ment;
3. It is affected by earlier treatment (A0).
As a motivating example, consider an observa-
tional study of the effect of erythropoietin alpha
(EPO) on mortality in a population with end-stage
renal disease (ESRD) receiving hemodialysis. Pa-
tients on dialysis tend to be anemic, as commonly
measured via hematocrit (Hct) or hemoglobin levels.
EPO is used to treat the anemia and stimulate the
body’s production of red blood cells; Hct (L) thus
satisfies covariate characteristic 3. Furthermore, pa-
tients with more severe anemia (lower Hct) typically
receive higher doses of EPO (characteristic 2), and
sicker patients tend to be more anemic [character-
istic 1(b)]. Both these characteristics 1 and 2 make
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Fig. 1. Causal diagram for time-varying treatment.
Hct a confounder of the effect of later treatment,
requiring adjustment to estimate the effect of EPO
A1. Observational studies of the effect of extended
EPO dosing on mortality will thus be characterized
by confounding by a variable (Hct) affected by treat-
ment.
In settings like the above, where the interest lies
in estimating the joint effect of a sequence of treat-
ments, standard methods which attempt to estimate
these effects simultaneously (e.g., regression of Y on
A0 and A1 or some function of both) will be inap-
propriate, whether or not one adjusts for or con-
ditions on the confounder L. Characteristics 1(a)
and 3 make Hct (L) an intermediate variable on the
pathway from early EPO treatment A0 to outcome
Y ; adjustment for it blocks the path A0 → L→ Y ,
making it impossible to find the part of the effect of
early EPO treatment (A0) mediated by Hct. Char-
acteristics 1(b) and 3 make Hct (L) a so-called col-
lider (Pearl (1995)) on the path A0→ L← U → Y ;
conditioning on or adjusting for it induces associa-
tions between A0 and Y even if no effect of A0 on
Y exists.
Over an extended period of time, James Robins
(with some help from collaborators) introduced
three basic approaches for dealing with such con-
founding: the parametric G-formula (Robins (1986)),
structural nested models (Robins (1989); Robins
et al. (1992)) with the associated method of G-
estimation and marginal structural models (Robins,
Hernan and Brumback, 2000) with the associated
method of inverse probability of treatment weight-
ing. As we will argue throughout this paper, SNMs
and G-estimation are, in principle, better tailored
for dealing with failure of the usual assumptions of
no unmeasured confounders or sequential ignorabil-
ity often used to justify the application of all of these
methods, as well as with (near) positivity violations
whereby certain strata contain (nearly) no treated
or untreated subjects (Robins (2000)). Despite these
advantages, the application of these methods in ap-
plied research has been relatively infrequent.
Broadly speaking, there are two types of SNMs:
models for the effect of a treatment or sequence of
treatments on the mean of an outcome, and models
for the effect of a treatment on the entire distribu-
tion of the outcome(s). The former include struc-
tural nested mean models (SNMMs), which have
close links to structural nested cumulative failure
time models (SNCFTMs) for survival outcomes; the
latter include structural nested distribution mod-
els (SNDMs), which have close links to structural
nested failure time models (SNFTMs) for survival
outcomes. For pedagogic purposes, we will introduce
these models first for point treatments (i.e., treat-
ments which are administered at one specific time
point) in Section 2. We then discuss identifying as-
sumptions and the associated G-estimation method
in Section 3, and contrast it with alternative esti-
mation methods for the effect of a point treatment
in Section 4. These results are extended to time-
varying treatments in Sections 5 and 6. We show
how to predict the effects of interventions in Sec-
tion 7, examine extensions to mediation analysis in
Section 8 and conclude with a discussion.
2. STRUCTURAL MODELS FOR POINT
TREATMENTS
2.1 Structural Mean Models
Let Y a denote the outcome in a given subject that
would be seen were the subject to receive treatment
a. This variable is a potential outcome, which we
connect to the observed outcome through the consis-
tency assumption that Y = Y a if the observed treat-
ment A= a; otherwise, Y a is counterfactual. Causal
effects can now be defined as comparisons of poten-
tial outcomes Y a and Y a
†
for the same individual
subject or group of subjects for different treatments
a and a† (Rubin (1978); Robins (1986)). In partic-
ular, letting a† = 0 for notational convenience, av-
erage causal effects can be defined in terms of com-
parisons of average potential outcomes, for exam-
ple, E(Y a | L = l,A = a) − E(Y 0 | L = l,A = a) or
E(Y a | L= l,A= a)/E(Y 0 | L= l,A= a).
Structural Mean Models (SMMs) (Robins, 1994,
2000) parameterize average causal effects in subjects
receiving level a of treatment as
g{E(Y a | L= l,A= a)}
(1)
− g{E(Y 0 | L= l,A= a)}= γ∗(l, a;ψ∗),
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for all l and a. Here, g(·) is a known link func-
tion (e.g., the identity, log or logit link), γ∗(l, a;ψ)
is a known function, smooth in ψ and satisfying
γ∗(l,0;ψ) = 0 for all l and ψ. Here and throughout,
ψ∗ is the true unknown finite-dimensional parame-
ter. With a= 0 encoding absence of treatment—as
we will assume throughout—SMMs thus express the
effect of removal of treatment on the outcome mean.
Typically, the parameterization is chosen to be
such that γ∗(l, a; 0) = 0 for all a and l, so that ψ∗ = 0
encodes the null hypothesis of no treatment effect.
For instance, for scalar covariate L one may consider
the additive or linear SMM [which uses the identity
link g(x) = x]:
E(Y a | L= l,A= a)−E(Y 0 | L= l,A= a)
(2)
= (ψ∗0 +ψ
∗
1l)a,
for unknown ψ∗0 , ψ
∗
1 . With A a binary exposure
coded as 1 for treatment and 0 for no treatment,
ψ∗0 thus encodes the average treatment effect in the
treated with covariate value L = 0, and ψ∗1 mea-
sures how much the average treatment effect in the
treated differs between subgroups with a unit differ-
ence in L. Likewise, the multiplicative or loglinear
SMM uses the log link g(x) = log(x), for example,
E(Y a | L= l,A= a)
E(Y 0 | L= l,A= a)
= exp{(ψ∗0 +ψ
∗
1l)a},
and the logistic SMM uses the logit link g(x) =
logit(x), for example,
odds(Y a = 1 | L= l,A= a)
odds(Y 0 = 1 | L= l,A= a)
= exp{(ψ∗0 +ψ
∗
1l)a},
where odds(V = 1 |W ) ≡ P (V = 1 |W )/P (V = 0 |
W ) for random variables V and W . If treatment A
can take on more than two values, then—without
additional assumptions—the function γ∗(l, a;ψ∗)
cannot be interpreted simply as a dose response
function. This is because a dose response would
contrast outcomes in the same subset at different
levels of a [i.e., contrast E(Y a | L = l,A = a) with
E(Y a
′
| L = l,A = a) for a 6= a′], whereas the func-
tions γ∗(l, a;ψ∗) and γ∗(l, a′;ψ∗) for a 6= a′ contrast
causal effects for two different groups (namely, those
with A= a versus A= a′, but the same L= l). We
will revisit this subtlety in Section 7.
One can use a SMM to construct a variable U∗(ψ)
whose mean value (in a subset of individuals with
given covariates and treatment) equals the mean
outcome that would have been seen had treatment
been removed from that subset. Let
U∗(ψ)≡ Y − γ∗(L,A;ψ),
if g(·) is the identity link,
U∗(ψ)≡ Y exp{−γ∗(L,A;ψ)},
if g(·) is the log link and
U∗(ψ)
(3)
≡ expit[logit{E(Y | L,A)} − γ∗(L,A;ψ)],
if g(·) is the logit link. Then
E{U∗(ψ∗) | L,A}=E(Y 0 | L,A).(4)
This identity will be central to the estimation meth-
ods for ψ∗ that we will describe in Section 3. We
could have defined U∗(ψ) in general—and in par-
ticular for the identity and log link—as U∗(ψ) ≡
g−1[g{E(Y | L,A)} − γ∗(L,A;ψ)]. We have avoided
doing this for the identity and log links as it makes
the definition of U∗(ψ) dependent on the expecta-
tion E(Y | L,A), which can be undesirable when
this demands additional modeling. However, this
(or some alternative) is unavoidable for the logit
link. Special estimation methods will therefore be
required for logistic SMMs.
SMMs can also be used to describe the effect of
a multivariate point treatment. For instance, for
a bivariate treatment A = (A(1),A(2))′, one may
use a SMM with γ∗(L,A;ψ) = ψ1A
(1) + ψ2A
(2) +
ψ3A
(1)A(2) to describe the effect of setting both
treatments to zero. When primary interest lies in the
interaction (ψ3) between A
(1) and A(2) in their effect
on the outcome, then one may instead consider the
class of less restrictive Structural Mean Interaction
Models (Vansteelandt et al. (2008a); Tchetgen Tch-
etgen (2012)). To guard against misspecification of
the main treatment effects, these further relax the
SMM restrictions by merely parameterising the con-
trast between the effects of A(1) when A(2) is set to
some value a(2) versus zero (or of the effects of A(2)
when A(1) is set to some value a(1) versus 0):
g{E(Y a
(1),a(2) |A= a,L= l)}
− g{E(Y 0,a
(2)
|A= a,L= l)}
− g{E(Y a
(1),0 |A= a,L= l)}(5)
+ g{E(Y 0,0 |A= a,L= l)}
= γ∗(l, a(1), a(2);ψ∗),
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for a= (a(1), a(2))′; here, γ∗(l, a(1), a(2);ψ) is a known
function which encodes the interaction between both
treatments, and which must be smooth in ψ and
satisfy γ∗(l,0, a(2);ψ) = γ∗(l, a(1),0;ψ) = 0 for all
l, a(1), a(2) and ψ. For instance, the natural choice
γ∗(l, a(1), a(2);ψ) = ψa(1)a(2) imposes that the inter-
action between both exposures is the same at all
levels of l.
2.2 Structural Distribution Models
When the outcome mean does not adequately
summarize the data or the interest lies more broadly
in evaluating treatment effects on the outcome
distribution, then Structural Distribution Models
(SDMs) can be used instead. These are closely re-
lated to SMMs, but instead map percentiles y of
the conditional distribution of Y a, given L= l and
A = a, into percentiles γ(y, l, a;ψ∗) of the condi-
tional distribution of Y 0, given L= l and A= a. In
particular, they postulate that
FY 0|L=l,A=a{γ(y, l, a;ψ
∗)}= FY a|L=l,A=a(y),(6)
for all l and a. As with SMMs, γ(y, l, a;ψ) is a known
function, smooth in ψ and satisfying γ(y, l,0;ψ) =
y for all y, l. With a = 0 encoding the absence of
treatment, SDMs thus express the effect of removing
treatment on the outcome distribution rather than
the outcome mean.
Typically the parameterisation of a SDM is chosen
to be such that γ(y, l, a; 0) = y, so that ψ∗ = 0 en-
codes the null hypothesis of no treatment effect. For
instance, for scalar covariate L, one could assume
that
FY 0|L=l,A=a(y −ψ
∗
0a−ψ
∗
1al)
(7)
= FY a|L=l,A=a(y),
for all l and a. This characterizes a location shift
model following which the conditional distribution
of Y 0, given L and A, can be obtained by shifting
the conditional distribution of Y , given L and A,
by −ψ∗0A− ψ
∗
1AL. One can use this to construct a
variable
U(ψ∗)≡ γ(Y,L,A;ψ∗)
whose distribution (in a subset of individuals with
given covariates and treatment) is the same as that
of the outcome that would have been seen had treat-
ment been removed from that subset, in the sense
that
FY 0|L,A(y) = FU(ψ∗)|L,A(y);(8)
for example, U(ψ) = Y −ψ0A−ψ1AL in the location
shift example. This will be useful for the estimation
of ψ∗.
SDMs have a stronger variant called rank preserv-
ing SDMs (Robins and Tsiatis (1991)), which pos-
tulate that
Y 0 = γ(Y,L,A;ψ∗).
For instance, a stronger variant of the location shift
model of the previous paragraph assumes that Y 0 =
Y −ψ∗0A−ψ
∗
1AL. By making a mapping between the
potential outcomes themselves (rather than between
distributions), such rank preserving SDMs are eas-
ier to understand and communicate. However, they
are seldom plausible because they impose that the
rankings of two subjects with different outcome val-
ues but identical treatment and covariates are pre-
served after mapping into Y 0 (hence the term “rank
preserving”). In particular, they assume that sub-
jects with identical outcome, treatment and covari-
ate values experience identical treatment effects.
Location shift SDMs like (7) make substantially
stronger assumptions than correspondingly parame-
terized SMMs. The distribution models assume that
treatment level a shifts each percentile of the con-
ditional distribution of Y , given L = l,A = a by a
value γ∗(l, a;ψ∗) constant for all y [i.e., γ(y, l, a;ψ) =
y − γ∗(l, a;ψ)], whereas the mean model assumes
only a mean shift of γ∗(l, a;ψ). When location shift
is implausible, it can sometimes be made more plau-
sible by transforming y. For instance, for strictly
positive y, one might obtain a location shift SDM
by defining γ(y, l, a;ψ) = exp{log(y) − γ(l, a;ψ)}.
There will then be a correspondence between the
parameters of the SDM and those of a SMM for
log(y)− log{γ(y, l, a;ψ)}.
The parameterization and interpretation of SDMs
that are not simply shift models can be tricky. This
is because, by the nature of the cumulative distri-
bution function, the function γ(y, l, a;ψ) must be
increasing in y for each l, a and ψ, and it may be
difficult to impose that. For instance, the function
γ(y, a, l;ψ) = y − aψ1 − yaψ2 may appear natural,
but is not guaranteed increasing in y. An alterna-
tive function which is naturally increasing in y is
γ(y, a, l;ψ) = y exp(−aψ2) − aψ1. Here, interpreta-
tion is somewhat subtle; while ψ2 expresses the ef-
fect of treatment A on the residual variability of Y ,
it also has implications for the effect of treatment on
the mean of Y , and so ψ1 cannot be interpreted sim-
ply as the effect of treatment on the mean outcome,
unless ψ2 = 0.
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SDMs lend themselves naturally to the analysis of
failure times. For instance, consider model (6) with
T a, T 0 and t substituting for Y a, Y 0 and y. Then
the choice γ(t, a, l;ψ) = t exp(aψ0+alψ1) implies the
failure time model defined by
ST 0|L=l,A=a{t exp(−aψ
∗
0 − alψ
∗
1)}= ST |L=l,A=a(t),
for all l and a, where S(·) denotes the survival func-
tion. This model, which is an example of a Struc-
tural Accelerated Failure Time Model (SAFTM)
(Robins (1989); Robins and Tsiatis (1991); Robins
(1992); Robins et al. (1992)), expresses that treat-
ment lengthens lifetime by a factor exp(aψ∗0 +alψ
∗
1)
(in distribution) among subjects with treatment a
and covariate l.
2.3 Structural Mean and Distribution Models for
Repeated Measures Outcomes
Structural mean and distribution models require
some modification for repeated measures outcomes.
The modifications for SMMs are simpler, but also
allow a new class of models for discrete-time fail-
ures. Extension of SDMs is more complicated. We
consider these in order.
We begin with some notation common to both
types of models. Suppose that measurements on ex-
posure and confounders are collected at time point
t0 and that outcome measurements are recorded at
fixed later time points t1, . . . , tK+1. Let for a vari-
able X , Xk denote the level of the variable that one
obtains at time tk. We use overbars to denote the
history of a variable; thus, Xk = {X0,X1, . . . ,Xk}
denotes the history of X through tk. We use un-
derbars to denote the future of a variable; thus,
Xk ≡ {Xk, . . . ,XK+1}. Finally, we use X as short-
hand notation for X1 and Xk:m for m≥ k to denote
(Xk, . . . ,Xm).
2.3.1 Structural mean models and structural cu-
mulative failure-time models Extension of SMMs to
repeated measures is relatively straightforward, be-
cause they model separately the effect of a treatment
on each component outcome. SMMs parameterize
contrasts of Y a and Y 0 as
g{E(Y a | L= l,A= a)} − g{E(Y 0 | L= l,A= a)}
= γ∗(l, a;ψ∗),
for all l and a. Here, g(·) is a known (K + 1)-
dimensional link function, γ∗(l, a;ψ) is a known
(K + 1)-dimensional function with components
γ∗k(l, a;ψ), k = 1, . . . ,K + 1, that parameterize the
effect of treatment on Yk. These components are
smooth in ψ and satisfy γ∗k(l,0;ψ) = 0 for all l and
ψ. For instance, the SMM defined by
E(Y ak | L= l,A= a)−E(Y
0
k | L= l,A= a)
= (ψ∗0 +ψ
∗
1l)a(tk − t0),
for k = 1, . . . ,K + 1, expresses that the effect of
treatment a may depend on covariates l and changes
linearly over time, being zero at the baseline time t0.
Under this repeated measures SMM, as in Sec-
tion 2.1, it is possible to define a transformation
U∗(ψ) of the observed outcome vector Y so that
E{U∗(ψ∗) | L,A}=E(Y 0 | L,A).
Here, U∗(ψ) is a vector with components Yk−γ
∗
k(L,
A;ψ) for k = 1, . . . ,K + 1 if g(·) is the identity
link, Yk exp{−γ
∗
k(L,A;ψ)} if g(·) is the log link, and
expit[logit{E(Yk | L,A)} − γ
∗
k(L,A;ψ)] if g(·) is the
logit link.
Structural Cumulative Failure Time Models
(SCFTMs; Picciotto et al. (2012)) are a variant of
repeated measures loglinear SMMs for the modeling
of cumulative failure time probabilities:
P (T a < tk | L= l,A= a)
P (T 0 < tk | L= l,A= a)
= exp{γ∗k(l, a;ψ
∗)},
for all l, a and k = 1, . . . ,K + 1. A limitation of this
class of models is that their parameterization can be
tricky when the cumulative probability of failure be-
comes large, because the model does not restrict the
outcome probabilities to stay below 1. Martinussen
et al. (2011) independently proposed a continuous-
time version of this model and lay out connections
with additive hazard models.
2.3.2 Structural distribution models For multi-
variate outcomes, SDMs parameterize the effect of a
treatment A on the marginal distribution of the vec-
tor of future potential outcomes Y a. This mapping
is typically done recursively, taking the components
Y ak and Yk in forward sequence. These models are
therefore most easily understood by first considering
the class of more restrictive rank-preserving SDMs,
which postulate that, for subjects with A = a and
L= l:
Y 0k = γk(Yk, Y k−1, l, a;ψ
∗)(9)
for k = 1, . . . ,K + 1. Here, γk(yk, yk−1, l, a;ψ) is a
known function, smooth in ψ and monotonic in yk,
and γk(yk, yk−1, l,0;ψ) = yk for all yk, l, and ψ. For
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instance, with two time points (K = 1), a rank pre-
serving SDM may be given by the following set of
restrictions:
Y 02 = Y2 − (ψ
∗
1 + ψ
∗
2Y1)A,
(10)
Y 01 = Y1 −ψ
∗
3A.
If the effect of A on Y2 varies with Y1, as in this ex-
ample, then one must model this explicitly since the
model would otherwise—perhaps unrealistically—
assume that treatment does not affect the corre-
lation between repeated outcomes (conditional on
A,L). This is unlike in SMMs where one can average
the effect of A on Y2 over all Y1-values. This makes
it substantially more difficult to parameterize SDMs
than SMMs. It moreover complicates the interpre-
tation of effects; for example, ψ∗1 in (10) is difficult
to interpret when ψ∗2 6= 0 since it expresses the ef-
fect of treatment on Y2 in subjects with A= 1 and
Y1 = 0, where Y1 may itself be affected by treatment.
Equation (10) may hence by easier to interpret upon
re-expressing it as
Y 02 = Y2 −{ψ
∗
1 + ψ
∗
2(Y
0
1 + ψ
∗
3A)}A
= Y2 − (ψ
∗
1 + ψ
∗
2Y
0
1 +ψ
∗
2ψ
∗
3A)A.
A SDM relaxes the restrictions of the rank-
preserving SDM by demanding that the equality (9)
merely holds in distribution, conditional on L = l
and A = a. Assuming that given L and A, Y has
a continuous multivariate distribution with proba-
bility 1, a SDM can thus be defined by the set of
restrictions
FY 0|L=l,A=a{γ(y, l, a;ψ
∗)}= FY a|L=l,A=a(y)
= FY |L=l,A=a(y),
for all l, a, where
γ(y, l, a;ψ∗)≡ {γ1(y1, l, a;ψ
∗),
γ2(y2, l, a;ψ
∗), . . . ,
γK+1(yK+1, l, a;ψ
∗)}
is given by (Robins, Rotnitzky and Scharfstein
(2000)):
γ1(y1, l, a;ψ
∗) = F−1
Y 01 |L=l,A=a
◦ FY1|L=l,A=a(y1),
γk(yk, l, a;ψ
∗) = F−1
Y 0
k
|L=l,A=a,Y
0
k−1=γ1:k−1(yk−1,l,a;ψ
∗)
◦ FYk|L=l,A=a,Y k−1=yk−1
(yk),
for k = 2, . . . ,K + 1. For instance, the SDM corre-
sponding to (10) may be written:
FY 01 |L=l,A=a(y1 −ψ
∗
3a)
= FY1|L=l,A=a(y1),
(11)
FY 02 |L=l,A=a,Y 01 =y1−ψ∗3a{y2 − (ψ
∗
1 +ψ
∗
2y1)a}
= FY2|L=l,A=a,Y1=y1(y2).
The decomposition of the causal effects in the blip
functions γk(yk, l, a;ψ
∗) is recursive because one
must model not merely average effects but instead
the full mapping between distributions. In partic-
ular, the effect of treatment on the first potential
outcome is modeled first; then, mapping between
distributions is done successively for the outcome at
successive times. The overall blip function encoded
by γ(·) and the first element of this function has
the usual structure and interpretation of causal es-
timands; that is, as a comparison of distributions
of potential outcomes under different interventions
for the same group of subjects. However, the com-
ponent functions γk(·), k > 1 do not in general have
this interpretation, since the conditioning in these
mapping functions is not common between Y 0k and
Yk; for instance, the left-hand side of (11) conditions
on Y 01 , whereas the right-hand side conditions on Y1.
Nonetheless, these component functions are causal
in the sense that they represent the impact of treat-
ment on the conditional distribution of a variable.
This feature is shared with the causal rate or hazard
ratio (Hernan, 2010). Under the strong assumption
of rank preservation, the conditioning is on a com-
mon variable, and so then the components of the
blip function do have a standard causal interpreta-
tion.
For repeated measures outcomes, SDMs corre-
spond with similarly parameterized SMMs if the
SDMs are shift models. In a shift SDM, the com-
ponent functions γk(yk, yk−1, l, a) may be written as
γk(yk, yk−1, l, a) = yk−γ
∗
k(l, a;ψ). These require that
the shift in percentiles of the distribution of yk not
only be independent of yk but also of yk−1. Thus,
shift SDMs make substantially stronger assumptions
than similarly parameterized SMMs.
Under the SDM, a (K + 1)-dimensional vari-
able U(ψ∗) = {U1(ψ
∗), . . . ,UK+1(ψ
∗)} can be con-
structed with components Uk(ψ) = γk(Y k,L,A;ψ).
This vector mimics the counterfactual outcome vec-
tor Y 0 in the sense that
P{U(ψ∗)> y | L,A}= P (Y 0 > y | L,A}.
This result will be useful for estimation.
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2.4 Retrospective Blip Models
The blip functions and causal models discussed
above largely consider the effect of a blip of treat-
ment conditional only on treatment and baseline
covariates; the sole exception has been SDMs for
repeated measures outcomes, where the effect of
treatment on later outcomes is modeled addition-
ally conditional on earlier outcomes, and where the
interpretation of the model parameters is not clear
as a usual causal contrast. This focus is consistent
with an orientation of the models to be more di-
rectly useful for making decisions, where the effect
of treatment is modeled conditional only on infor-
mation available at the time of the decision.
For explanatory purposes, one can construct
structural models for the effect of a treatment con-
ditional on information not available at the time of
treatment. Such models may have explanatory uses
even though the quantities they model are less di-
rectly relevant for making decisions. Consider mod-
eling the effect of screening mammography on breast
cancer mortality (Joffe, Small and Hsu (2007)). To
a first approximation, one might assume that the
mammogram has an effect on death only among
subjects for whom it detects a tumor. Suppose that
some subjects undergo screening at the start of the
study (A= 1; A= 0 otherwise). Let L1 indicate 1 if
cancer is detected at time t1 after the start of the
study and 0 otherwise. It is of interest to know how
much the screening mammogram affects mortality
for subjects for whom it is effective in detecting can-
cer. We can then model the effect of the treatment
on the outcome using a retrospective SDM (RSDM)
or SFTM, which conditions on L1 in addition to
treatment and baseline covariates:
FY 0|L0=l0,L1=l1,A=a{γ(y, l0, l1, a;ψ
∗)}
(12)
= FY |L0=l0,L1=l1,A=a(y).
In this example, we might assume that γ(y, l0,0, a;
ψ∗) = y to reflect that screening has no effect in
subjects for whom no tumor is detected. Note that
though L1 may be affected by A, conditioning on
it does not distort the interpretation of the param-
eters as encoding a causal effect because identity
(12) still involves a comparison of the same subjects
(those with L0 = l0,L1 = l1,A = a) under different
interventions.
Models of this sort might also be useful in de-
termining whether the effect of a treatment given
at baseline is modified by post-treatment covari-
ates and so whether there are identifiable sub-
groups of subjects for whom treatment appears not
to be working (Stephens, Keele and Joffe (2013)).
Changes or additions to treatment might then be
proposed in such subgroups after baseline. Joffe,
Small and Hsu (2007) consider the relation be-
tween these retrospective models and the popular
approach of principal stratification (Frangakis and
Rubin (2002)). These models can generalize to a
sequence of time-varying treatments, where there
are additional justifications for their use (see Sec-
tion 5.3).
3. IDENTIFICATION AND ESTIMATION IN
STRUCTURAL MODELS FOR POINT
TREATMENTS
Two kinds of assumptions have been proposed for
use in most of the literature on estimation in SMMs
and SDMs: no unmeasured confounders and instru-
mental variables type assumptions. In this section,
we will focus on the former, and defer discussion of
the latter to Section 6.3.
3.1 Ignorability
The required no unmeasured confounders assump-
tion for the identification of the parameter ψ∗ index-
ing SMMs and SDMs can be formulated as
A⊥⊥ Y 0 | L,(13)
where U ⊥⊥ V | W for random variables U,V,W
denotes that U is conditionally independent of V ,
given W . This assumption, which is empirically un-
verifiable, expresses that L is sufficient to adjust for
confounding of the association between A and Y .
Assumption (13), which is also referred to as the
weak ignorability or exchangeability assumption, is
weaker than the strong ignorability assumption of
Rosenbaum and Rubin (1984) which, for binary
treatments, states that A⊥⊥ (Y 0, Y 1) | L. However,
it is generally difficult to imagine settings where as-
sumption (13) holds, but strong ignorability fails
(one exception might be settings where individuals
choose treatment on the basis of their perceived be-
lief of benefit, which may be correlated with actual
benefit Y 1 − Y 0). That (13) is a weaker assump-
tion is exhibited in the fact that, for binary treat-
ments, it only identifies the effect of treatment on
the treated—a contrast that has been of interest
8 S. VANSTEELANDT AND M. JOFFE
in econometrics and epidemiology (Greenland and
Robins (1986)):
E(Y 1 − Y 0 |A= 1,L)
=E(Y 1 |A= 1,L)−E(Y 0 |A= 1,L)
=E(Y 1 |A= 1,L)−E(Y 0 |A= 0,L)
=E(Y |A= 1,L)−E(Y |A= 0,L);
the second equality follows due to ignorability (13)
and the third due to the consistency assumption.
The parameters of SMMs, SDMs and SCFTMs rep-
resent the effect of treatment in the treated (or, more
generally, the effect of receiving treatment level a for
subjects who received level a of treatment), and so
this weaker assumption is sufficient for identifica-
tion.
It follows by a similar reasoning that the blip
functions in the SMMs and SDMs discussed in Sec-
tions 2.1–2.3 are nonparametrically just identified
under ignorability (Robins, Rotnitzky and Scharf-
stein (2000)). That is, the contrast of the outcomes
under the observed treatment and the outcomes that
would have been seen in the absence of treatment is
computable for each level of a and l (and, for SDMs,
of y) from the law of the observables without assum-
ing any restrictions or parameterization on these
functions. While such nonparametric identification
is of limited use in complex settings (especially with
time-varying treatments considered subsequently),
due to the curse of dimensionality (Robins and Ri-
tov (1997)), it does ensure the ability to check the
assumptions in any assumed causal model (provided
a sufficient sample size). In contrast, the retrospec-
tive blip functions considered in Section 2.4 are not
identified nonparametrically (Vansteelandt (2010);
Stephens, Keele and Joffe (2013)). Multiple retro-
spective blip models may thus explain the same law
of the observables equally well even under ignorabil-
ity.
3.2 Estimation Under Ignorability
The SMM together with the ignorability assump-
tion (13) implies that
E{U∗(ψ∗) | L,A}= E(Y 0 |A,L) =E(Y 0 | L)
= E{U∗(ψ∗) | L}.
Estimation of ψ∗ in a SMM can thus be based on
solving estimating equations:
0 =
n∑
i=1
[d∗(Ai,Li)−E{d
∗(Ai,Li) | Li}]
(14)
· [U∗i (ψ)−E{U
∗
i (ψ) | Li}],
which essentially set the empirical conditional co-
variance between U∗(ψ) and arbitrary functions
d∗(A,L) of the dimension of ψ, given L, to zero.
For instance, for model (2), the choice d∗(Ai,Li) =
(1,Li)
′Ai results in estimating equations
0 =
n∑
i=1
(
1
Li
)
{Ai −E(Ai | Li)}
· [Yi−E(Yi | Li)(15)
− (ψ0 +ψ1Li){Ai −E(Ai | Li)}],
from which estimates for (ψ0, ψ1) can be solved.
A locally efficient estimator of ψ∗ [under the SMM
together with the ignorability assumption (13)] can
be attained by setting
d∗(A,L) =E
{
∂U∗(ψ∗)
∂ψ
∣∣∣A,L},
when the variance of U∗(ψ∗) given A,L is constant;
local here means that the efficiency is only attained
when this constant variance assumption is met and
models for all conditional expectations involved in
(14) are correctly specified.
The SDM together with the ignorability assump-
tion (13) implies the more restrictive constraint that
U(ψ∗)⊥⊥A | L.(16)
This motivates estimating ψ∗ by picking the value
ψ that makes this conditional independence hold.
This forms the default approach in SAFTMs, where
estimation is based on a grid search whereby the
independence (16) is tested for different values of
ψ∗ using a (standard) statistical test until it is found
to be satisfied (Robins et al. (1992)). Equivalently,
estimation can be based on solving an estimating
equation of the form
0 =
n∑
i=1
d{Ui(ψ),Ai,Li}
−E[d{Ui(ψ),Ai,Li} | Li,Ui(ψ)]
(17)
−E(d{Ui(ψ),Ai,Li}
−E[d{Ui(ψ),Ai,Li} | Li,Ui(ψ)] |Ai,Li),
for ψ, where d{Ui(ψ),Ai,Li} is an arbitrary in-
dex function of the dimension of ψ; for example,
d{Ui(ψ),Ai,Li}= (1,Li)
′AiUi(ψ). A locally efficient
estimator of ψ∗ [under the SDM together with
the ignorability assumption (13)] can be obtained
by solving (17) with d{U(ψ),A,L} = E{Sψ(ψ) |
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U(ψ),A,L}, where Sψ(ψ) is the score for ψ under
the observed data likelihood
∂U(ψ∗)
∂Y
f(L)f{U(ψ∗) | L}f(A | L)(18)
with all components substituted by suitable para-
metric models (Robins (1997)). For instance, under
model (7) with U(ψ∗) given L following a normal
distribution with mean linear in L and constant vari-
ance, Sψ(ψ) = (1,L)
′A{aU(ψ) + bL+ c} for certain
constants a, b, c, so that a locally efficient estimator
is obtained by solving (15).
Estimating equations of form (14) and (17) may
also be used for repeated measures outcomes. In
(14), d∗(Ai,Li) now becomes a p×(K+1)-dimensio-
nal matrix, with p the dimension of ψ. In (17),
d{Ui(ψ),Ai,Li} remains an arbitrary index func-
tion of the dimension of ψ; for example, d{Ui(ψ),
Ai,Li}= (1,Li)
′Ai
∑K+1
m=1 Uim(ψ).
Remark. Note that the SMM together with as-
sumption (13) is the same model for the observables
as the semiparametric regression model (Chamber-
lain (1987)):
g{E(Y | L,A)}= ω(L) + γ∗(L,A;ψ∗),(19)
with ω(L) unspecified. Likewise, the SAFTM [with,
e.g., γ(t, a, l;ψ) = t exp(−aψ)] together with as-
sumption (13) can be viewed as a semiparamet-
ric generalization of the accelerated failure time
model (Wei (1992)), defined by logT = ψA+ ε with
ε⊥⊥A | L.
Because of the curse of dimensionality, evaluating
the conditional expectations appearing in equations
(14) and (17) requires a parametric working model
A for the conditional distribution of the exposure A:
f(A | L) = f(A | L;α∗);
here f(A | L;α) is a known density function, smooth
in α, and α∗ is an unknown finite-dimensional pa-
rameter. For instance, for dichotomous exposure,
one could assume that P (A = 1 | L) = expit(α∗0 +
α∗1L) with α
∗ = (α∗0, α
∗
1)
′. Here, α∗ can be estimated
via standard (maximum likelihood) methods.
Evaluating (14) and (17) moreover requires a
parametric working model B for the conditional dis-
tribution of U(ψ∗) or the conditional expectation of
U∗(ψ∗). For (17), we model:
f{U(ψ∗) | L}= f{U(ψ∗) | L;β∗},
where f{U(ψ∗) | L;β} is a known density func-
tion, smooth in β, and β∗ is an unknown finite-
dimensional parameter; to evaluate equations (14),
specification of the conditional mean of U∗(ψ∗),
given L, suffices. For instance, for a continuous out-
come, one could assume that conditional on L and
for given ψ∗, U(ψ∗) = Y −ψ∗0A−ψ
∗
1AL is normally
distributed with mean β∗0 + β
∗
1L and variance β
∗2
2 ,
with β∗ = (β∗0 , β
∗
1 , β
∗
2)
′. For each fixed value of ψ∗,
β∗ can be estimated using standard regression meth-
ods.
A consistent estimator of ψ∗ indexing the SMM or
SDM can now be obtained by solving equations (14)
or (17), respectively, with α∗ and β∗ substituted by
consistent estimators under models A and B, respec-
tively. The resulting estimator of ψ∗ is called a G-
estimator. In SDMs and linear or loglinear SMMs, it
has the attractive property of being doubly robust
(Robins and Rotnitzky, 2001): consistent when ei-
ther model A or model B is correctly specified (in
addition to a correctly specified structural model
and ignorability); it does not require both to be cor-
rectly specified, nor does it require specifying which
of both is correctly specified. That the solution to
equation (14) is doubly robust can be seen because
this equation has mean zero at ψ = ψ∗ when either
model A or model B is correctly specified, even if
one of them is misspecified. Equation (17) is like-
wise seen to have mean zero at ψ = ψ∗ under model
B; that it also has mean zero under model A at
ψ = ψ∗ is seen by rewriting the equation as
0 =
n∑
i=1
d{Ui(ψ),Ai,Li}
−E[d{Ui(ψ),Ai,Li} | Li,Ai]
−E(d{Ui(ψ),Ai,Li}
−E[d{Ui(ψ),Ai,Li} | Li,Ai] | Ui(ψ),Li).
The result now follows, provided that the param-
eters α and β are variation-independent (i.e., not
functionally related), so that a consistent estima-
tor of α∗ does not require consistent estimation of
β∗ and vice versa. Sandwich standard errors are
obtained via the usual estimating equations the-
ory.
In logistic SMMs, to the best of our knowledge,
no estimators of ψ∗ have been found that are root-n
consistent under model A and the ignorability as-
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sumption. This is because the evaluation of U∗(ψ)
is anyway dependent upon a model for the condi-
tional mean E(Y | A,L) [see (3)]. Tchetgen Tchet-
gen, Robins and Rotnitzky (2010) show that dou-
ble robustness can instead be attained against mis-
specification of either a model for the density f(Y |
A= 0,L) or a model for the density f(A | Y = 0,L).
Their key to estimation of ψ∗ is that the parameter-
ized association γ∗(L,A;ψ) between A and Y , when
evaluated at ψ = ψ∗, can be used to render A and
Y conditionally independent (given L) via inverse
probability weighting. Their results apply equally to
case-control designs (Tchetgen Tchetgen and Rot-
nitzky (2011)).
For Structural Mean Interaction Models, inference
is developed in Vansteelandt et al. (2008a) when g(·)
is the identity or log link and in Tchetgen Tchetgen
(2012) when g(·) is the logistic link. Tchetgen Tch-
etgen and Robins (2010) focus on case-only designs
and note that when g(·) is the log link, the mul-
tiplicative interaction (5) is identical to the condi-
tional odds ratio between A(1) and A(2), given L
within the subgroup of cases. This enables the use
of results on logistic SMMs (Tchetgen Tchetgen,
Robins and Rotnitzky (2010)) for robust estima-
tion of multiplicative interactions under outcome-
dependent sampling.
3.3 Censoring
Censoring presents additional challenges for the
analysis of failure-time outcomes T . Random censor-
ing or loss to follow-up can be dealt with through
inverse probability of censoring weighting (Robins
et al. (1992)). Type I censoring, also known as cen-
soring by end of follow-up, can be ignored in the
analysis of SCFTMs, but must be dealt with in a
different fashion in the analysis of SAFTMs. This is
because U(ψ∗) involves the failure-time itself, which
is missing for all subjects who fail after planned end-
of-follow-up; the coarsening process is informative
here as it depends on the actual failure time. We
will next describe how Type I censoring can be dealt
with in the analysis of SAFTMs.
Let C denote the planned end of follow-up time
for given individual. C is known for all subjects,
even those observed to fail. However, U(ψ) cannot
be evaluated for those who do not fail prior to time
C. Knowing that U(ψ∗)⊥⊥A | L under ignorability,
the aim is then to find a function q{U(ψ),C} which
is observable for all individuals and for which
q{U(ψ∗),C} ⊥⊥A | L.
If such function is found, then ψ∗ can be estimated
by solving the original estimating equations for
SDMs with q{U(ψ),C} replacing U(ψ). A natural
choice would be q{U(ψ),C}=min{U(ψ),U(C,A,L;
ψ)} with U(C,A,L;ψ) the blipped-down censor-
ing time, which is defined like U(ψ) but with T
substituted by C. However, this choice would not
satisfy the required conditional independence prop-
erty. The reason is that since C is fixed by de-
sign, U(C,A,L;ψ) will in general be a function of
A when ψ 6= 0 and so will generally fail to be con-
ditionally independent of A, given L. Robins and
Tsiatis (1991) thus propose to eliminate the de-
pendence of U(C,A,L;ψ) on A by redefining it to
be C(ψ)≡mina{U(C,a,L;ψ)}. By thus minimizing
over all feasible treatments a, any dependence on
the observed treatment is broken so that X(ψ) ≡
min{U(ψ),C(ψ)} and ∆(ψ)≡ I{U(ψ) < C(ψ)} be-
come always observable quantities that are indepen-
dent of A given L under ignorability, when evaluated
at ψ∗. We may thus choose q{U(ψ),C} to be an ar-
bitrary function of X(ψ) and ∆(ψ).
With each choice of q{U(ψ),C}, some subjects
who are observed to fail may be treated as cen-
sored when ψ 6= 0. This can happen because for
some subjects, C(ψ) may be smaller than U(ψ)
even though T < C. Such subjects are called artifi-
cially censored. Artificial censoring has several con-
sequences. Besides decreasing information about ψ∗
as more subjects are artificially censored, the es-
timating equations are not, in general, continuous
in ψ. This is because the functions q{U(ψ),C} are
not generally continuous in ψ, which happens in
part because ∆(ψ) is not a smooth function of ψ.
This can present problems for optimization, espe-
cially when ψ is a vector, and may moreover imply
that the estimating equations have no solution in
finite samples. This problem may be mitigated by
choosing q{U(ψ),C} to be a smooth function of ψ,
for example, q{U(ψ),C} = ∆(ψ)wα{X(ψ)/C(ψ)},
where wα(t) ≡ I(t > 1− α)(1 − t)/α+ I(t ≤ 1− α)
(Joffe, Yang and Feldman, 2012). Vock et al. (2013)
consider functions q(·;ψ) whose first derivatives ex-
ist for all ψ; they appear to have had better suc-
cess in convergence for their optimization algo-
rithm.
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4. PROPERTIES OF G-ESTIMATION IN
STRUCTURAL MODELS FOR POINT
TREATMENTS UNDER IGNORABILITY
4.1 Comparison with Ordinary Regression
Estimators
Insight into the behavior of G-estimators can be
garnered by focusing on the simple model MSMM
defined by the ignorability assumption that Y a ⊥
⊥ A | L for a = 0,1, known treatment mechanism
f(A | L) and the SMM
E(Y a − Y 0 |A= a,L) = ψ∗a.
Under homoscedasticity (i.e., when the conditional
variance of the outcome, given A and L, is a constant
σ2), the locally efficient G-estimator of ψ∗ under
modelMSMM has influence function (Newey (1990))
E{Var(A | L)}−1{A−E(A | L)}
(20)
· {Y −ψ∗A−E(Y − ψ∗A | L)};
it can thus in particular be obtained by setting the
sample average of these influence functions to zero
and solving for ψ∗. For binary treatment A, lin-
ear regression adjustment for the propensity score
(Rosenbaum and Rubin (1984)) results in an esti-
mator of ψ∗ with influence function of the same
form (20), but with E(Y − ψ∗A | L) substituted
by the population least squares fit from a regres-
sion of Y − ψ∗A on the propensity score E(A |
L). Linear regression adjustment for the propensity
score can therefore be viewed as an inefficient and
nondoubly robust G-estimation approach (Robins,
Mark and Newey (1992)). The close relation be-
tween G-estimation and regression adjustment for
the propensity score is not maintained in nonlin-
ear models, where propensity score adjustment may
not only demand correct models for the propen-
sity score, but also for its association with outcome
(Vansteelandt and Daniel, 2014). In nonlinear mod-
els, due to non-collapsibility of the treatment effect
parameter (Greenland, Robins and Pearl (1999)), its
meaning may also change depending on whether co-
variates are adjusted for in addition to the propen-
sity score.
Ordinary regression estimators [in particular,
maximum likelihood estimators obtained by fitting
model (19) under a finite-dimensional parameteri-
zation of ω(L)] are at least as efficient as the pre-
viously considered G-estimators, provided correct
model specification. From the variance of the influ-
ence functions, we can deduce that the asymptotic
variance of the locally efficient G-estimator is
σ2
E{Var(A | L)}
,(21)
when there is homoscedasticity and the conditional
mean E(Y − ψ∗A | L) =E(Y |A= 0,L) is correctly
specified. The ordinary least squares (OLS) estima-
tor under the linear regression model E(Y |A,L) =
β′L + ψA has an asymptotic variance which is
smaller but, interestingly, usually not much smaller:
σ2
E[Var(A | L) + {E(A | L)− E˜(A | L)}2]
.
This follows from its influence function, which is of
the same form (20), but with E(A | L) substituted
by E˜(A | L), the population least squares fit from a
regression of A on L.
Despite their greater efficiency, ordinary regres-
sion estimators have a number of limitations not
shared by G-estimators, an important one being
their lack of extensibility to the analysis of sequen-
tial treatments (see Section 5). Furthermore, their
explicit reliance on a model for the association be-
tween outcome and covariates can be disadvanta-
geous when the treated and untreated subjects are
very different in their covariate distributions, for
then even well-fitting models for the outcome may
be prone to extrapolation bias (Rosenbaum and Ru-
bin (1984)). This is not the case for G-estimators
when they are based on a correctly specified model
(A) for the treatment process. This is also seen from
the form of the influence functions (20), following
which individuals in regions of little or no overlap
[i.e., at covariate values L where Var(A | L) is small]
will hardly contribute in the calculation of the G-
estimator because A − E(A | L) ≈ 0 for such indi-
viduals. As with other estimation approaches based
on propensity score adjustment (e.g., matching), the
information about ψ∗ will thus come primarily from
regions with sufficient overlap, which we view as de-
sirable. In contrast, OLS estimators are more sus-
ceptible to extrapolation bias since the leading term
A − E˜(A | L) in their influence functions may be
far from zero for individuals in regions of little or
no overlap. Finally, an advantage of G-estimation
methods is that they can incorporate a priori knowl-
edge on the exposure distribution. For instance,
Vansteelandt et al. (2008b) exploit knowledge on the
distribution of offspring genotypes given parental
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genotypes (based on Mendel’s law of segregation),
by using G-estimators to develop gene-environment
interaction tests that are robust against misspecifi-
cation of the effect of environmental exposures on
the outcome.
4.2 Comparison with Inverse Probability
Weighted Estimators
For the analysis of sequential treatments (see Sec-
tion 5), marginal structural models (MSM) (Robins,
Hernan and Brumback, 2000) and inverse proba-
bility weighted (IPW) estimators are much more
popular than SMMs and SDMs and G-estimators.
This is related to G-estimation being computation-
ally more demanding by the lack of off-the-shelf soft-
ware. It is thus of interest to compare the behaviour
of these estimators in a simple setting with dichoto-
mous treatment. Consider therefore model MMSM,
which is defined by the ignorability assumption that
Y a ⊥⊥ A | L for a = 0,1, known propensity score
E(A | L) and the nonparametric MSM
E(Y a) = α+ ψ∗a.
Note, since Y a ⊥⊥ A | L for a = 0,1, that ψ∗ =
E(Y 1 − Y 0) in both models MSMM and MMSM,
and thus defines the same parameter. Nonetheless,
model MMSM is less restrictive than model MSMM
in that it does not postulate that the treatment ef-
fect is homogeneous (i.e., constant over levels of L).
This explains why the asymptotic variance of the lo-
cally efficient IPW estimator under model MMSM,
which has influence function (Robins, Rotnitzky and
Zhao (1994))
A{Y −E(Y |A= 1,L)}
E(A | L)
−
(1−A){Y −E(Y |A= 0,L)}
1−E(A | L)
+E(Y |A= 1,L)−E(Y |A= 0,L)− ψ∗,
is strictly larger than the variance of the locally effi-
cient G-estimator (unless A and L are independent,
as may be the case when A refers to a randomized
treatment, in which case they are equally efficient).
In particular, the asymptotic variance of the locally
efficient IPW estimator equals
σ2E
{
1
Var(A | L)
}
,(22)
when the treatment effect is homogeneous. The dif-
ference between (21) and (22) can be sizeable when
the propensity score is close to zero or 1 for some
values of L for then Var(A | L) is close to zero and
thus 1/Var(A | L) can take on large values. In our
opinion, this difference is not usually offset by the
weaker restrictions imposed by the MSM. Indeed,
the marginal treatment effect would seldom be of
scientific interest when certain subjects are almost
precluded from receiving treatment or no treatment.
Moreover, the G-estimator retains a useful interpre-
tation even when the assumption of constant treat-
ment effects fails in the sense that E(Y 1− Y 0 |A=
1,L) = ψ(L) for some function ψ(L). Indeed, in that
case the locally efficient G-estimator converges to
E{Var(A | L)ψ(L)}
E{Var(A | L)}
,(23)
which continues to be useful as a weighted average
of treatment effects ψ(L), with most weight given to
strata with most information about the treatment
effect.
This difference in asymptotic variance between
both estimators becomes even more pronounced in
the likely event that the model for E(Y |A= 0,L) =
E(Y 0 | L) = E(Y − ψ∗A | L) is misspecified. Let
∆(L) = E(Y | A = 0,L) − E∗(Y | A = 0,L) denote
the degree of misspecification at covariate value
L, with E(Y | A = 0,L) the true expectation and
E∗(Y | A = 0,L) the expectation used for evaluat-
ing the locally efficient G-estimator. Furthermore,
assume that in truth the treatment effect is homo-
geneous. Then the asymptotic variance of the G-
estimator becomes
σ2
E{Var(A | L)}
+
E{Var(A | L)∆(L)2}
E{Var(A | L)}2
,
and the asymptotic variance of the previously con-
sidered IPW estimator becomes
σ2E
{
1
Var(A | L)
}
+E
[
{∆(L) + ψ∗E(1−A | L)}2
Var(A | L)
]
.
Consider now that model misspecification is more
likely in regions of little overlap. Then because
Var(A | L) ≈ 0 in these regions, model misspecifi-
cation in these regions will only have a minor im-
pact on the variance of the G-estimator, but a par-
ticularly strong impact on the variance of the lo-
cally efficient IPW estimator. Similar findings have
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estimators (Vansteelandt, Bekaert and Claeskens
(2012)).
While this contrast between G-estimation and
IPW-estimation under misspecification of the out-
come model could turn out to be somewhat less dra-
matic when the propensity score is not considered as
fixed and known, we believe that the above findings
more likely understate the factual differences if one
considers that mainstream applications are based
on sequential treatments (and thus even more vari-
able inverse probability weights) and on simple, in-
efficient inverse probability weighting methods. The
latter can be viewed as inducing extreme misspec-
ification in the outcome model as they amount to
setting E(Y | A = 1,L) = E(Y | A = 0,L) = 0. We
thus believe that more routine application of G-
estimation is warranted.
5. STRUCTURAL NESTED MODELS FOR
TIME-VARYING TREATMENTS
Before introducing SNMs for time-varying or se-
quential treatments, we consider the structure of
observed data in observational studies with re-
peated treatments and covariates, as well as def-
initions of causal effects in such setting. Suppose
that measurements are collected at fixed time points
t0, t1, . . . , tK+1. Let Ak denote the treatment pro-
vided at time tk, k = 0, . . . ,K, and Lk denote other
covariates measured at that time; Yk, the outcome
measured at time tk, k = 1, . . . ,K +1, is part of Lk.
We presume the variables are ordered L0, A0, L1,
A1, etc.; thus, covariates and outcome at tk precede
treatment at tk.
Let Y
am−1
m denote the outcome that would be seen
at time tm in a given individual were (s)he to re-
ceive treatment history am−1 through time tm−1.
The variables Y
am−1
m are potential outcomes, which
are again linked to the observed data via the consis-
tency assumption that Ym = Y
am−1
m if Am−1 = am−1.
We presume that treatment at or after tm cannot
affect outcome at times up to tm; thus, Y
am−1,am
m =
Y
am−1,a
†
m
m for am 6= a
†
m. Causal effects can now be
defined as comparisons of potential outcomes Y aK
for the same group of subjects for different treat-
ment histories aK , a
†
K , aK 6= a
†
K (Robins (1986)). If
the outcome is measured only at the end of a fixed
follow-up period, or only at a subset of the follow-
up times, we can let Ym = (·), where “·” denotes
missing or undefined values for the times where the
outcome is not measured. Most of the subsequent
presentation then applies to those settings.
5.1 Structural Nested Mean Models
Structural nested mean models (SNMMs) (Robins
(1994); Robins, Rotnitzky and Scharfstein (2000))
simulate the sequential removal of an amount
(“blip”) of treatment at tm on subsequent average
outcomes, after having removed the effects of all
subsequent treatments. Given a history am, define
the counterfactual history (am,0) as the history a
†
that agrees with am through time tm and is 0 there-
after. SNMMs then model the effect of a blip of
treatment at tm on the subsequent outcome means
when holding all future treatments fixed at their ref-
erence level 0; thus, they parameterize contrasts of
Y am,0m+1 and Y
am−1,0
m+1 conditionally on treatment and
covariate histories through tm as
g{E(Y am,0m+1 | Lm = lm,Am = am)}
− g{E(Y
am−1,0
m+1 | Lm = lm,Am = am)}
= γ∗m(lm, am;ψ
∗),
for eachm= 0, . . . ,K and (lm, am), where γ
∗
m(lm, am;
ψ) is a known (K + 1 −m)-dimensional function,
smooth in ψ, and for each lm, am−1 and ψ it is
by definition required that γ∗m(lm, am−1,0;ψ) = 0.
Alternatively, one may focus on the effect of treat-
ment on the end-of-study outcome Y ≡ YK+1 only,
in which case one obtains a SNMM of the form
g{E(Y am,0 | Lm = lm,Am = am)}
− g{E(Y am−1,0 | Lm = lm,Am = am)}
= γ∗m(lm, am;ψ
∗),
for eachm= 0, . . . ,K and (lm, am), where γ
∗
m(lm, am;
ψ) is now 1-dimensional. The above contrasts gen-
eralize the notion of the effect of treatment on the
treated to the setting of a sequence of treatments.
The name “nested” refers to the nesting across time,
of the subgroups defined by Lm and Am within
which the effects are evaluated.
Typically, the parameterization is chosen to be
such that γ∗m(lm, am; 0) = 0 for all lm, am so that
ψ = 0 encodes the null hypothesis of no treatment
effect. For instance, with 2 time points (K = 1) a
linear SNMM may be given by
E(Y
(a0,a1)
2 − Y
(a0,0)
2 | L1 = l1,A1 = a1)
= (ψ∗0 +ψ
∗
1l1 +ψ
∗
2a0)a1,
E(Y
(a0,0)
2 − Y
0
2 | L0 = l0,A0 = a0)
= (ψ∗3 +ψ
∗
4l0)a0,
E(Y
(a0,0)
1 − Y
0
1 | L0 = l0,A0 = a0)
= (ψ∗0 +ψ
∗
1l0)a0.
14 S. VANSTEELANDT AND M. JOFFE
Here, the first equation models the effect of A1 on
Y2, the second models the effect of A0 on Y2 and the
third models the effect of A0 on Y1, all within levels
of variables defined prior to the considered exposure.
Thus, ψ∗0 , ψ
∗
1 and ψ
∗
2 encode short-term treatment
effects, which are here assumed to be constant at all
time points, and ψ∗3 and ψ
∗
4 encode long-term treat-
ment effects. These effects are visualised in Figures 2
and 3 below. When interest merely lies in the effect
on the end-of-study outcome, then the above model
for Y1 can be ignored.
Under the SNMM, as in Section 2.1, it is possible
to define a transformation U∗m(ψ
∗) of Y m+1, whose
mean value equals the mean that would be observed
if treatment were suspended from time tm onward,
in the sense that
E{U∗m(ψ
∗) | Lm,Am−1 = am−1,Am}
(24)
=E(Y
am−1,0
m+1 | Lm,Am−1 = am−1,Am),
for m= 0, . . . ,K. Here, U∗m(ψ) is a vector with com-
ponents
Yk −
k−1∑
l=m
γ∗l,k(Ll,Al;ψ),
for k =m + 1, . . . ,K + 1 (or for k = K + 1 only if
interest merely lies in the effect on the end-of-study
outcome) if g(·) is the identity link, and
Yk exp
{
−
k−1∑
l=m
γ∗l,k(Ll,Al;ψ)
}
,
if g(·) is the log link. These equations formalize the
notion of peeling off or blipping down the treatment
effects over the treatment period from tm to tk−1.
For instance, in the previous example for 2 time
points,
U∗1 (ψ
∗) = Y2 − (ψ
∗
0 +ψ
∗
1L1 + ψ
∗
2A0)A1,
U∗0 (ψ
∗) = (Y1 − (ψ
∗
0 + ψ
∗
1L0)A0, Y2
Fig. 2. Visualisation of the effects E(Y
(a0,0)
1 − Y
0
1 | L0 = l0,A0 = a0) and E(Y
(a0,a1)
2 − Y
(a0,0)
2 | L1 = l1,A1 = a1). Lines
within the circles depict covariate strata; lines outside the circles depict exposure strata.
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Fig. 3. Visualisation of the effects E(Y
(a0,0)
2 − Y
0
2 | L0 = l0,A0 = a0). Lines within the circles depict covariate strata; lines
outside the circles depict exposure strata.
− (ψ∗0 +ψ
∗
1L1 +ψ
∗
2A0)A1
− (ψ∗3 + ψ
∗
4L0)A0)
′.
For link functions other than the identity and log
link, such a transformation can still be defined, but
depends on the observed data distribution in a com-
plicated and contrived way. For instance, when g(·)
is the logit link and there are 2 time points (K = 1),
then under the SNMM we have that
E(Y 02 | L0 = l0,A0 = a0)
= g−1[g{E(g−1[g{E(Y2 | L1,A1,A0 = a0)}
− γ∗1(L1,A1,A0 = a0;ψ
∗)]
| L0 = l0,A0 = a0)}
− γ∗0(l0, a0;ψ
∗)].
The calculation of U0(ψ) thus not only demands
knowledge of E(Y2 | L1,A1), but also of the distri-
bution of (L1,A1), given (L0,A0).
The effect of a sequential treatment on the fail-
ure time distribution can be parameterized through
a collection of SNMMs with log link, one for each
time point (Robins and Hernan, 2009; Picciotto et
al., 2012). In continuous time (Martinussen et al.
(2011)), such structural nested cumulative failure
time models are defined by restrictions of the form:
P (T am,0 > t | Lm = lm,Am = am, T ≥ tm)
P (T am−1,0 > t | Lm = lm,Am = am, T ≥ tm)
= exp{γ∗m(t, lm, am;ψ
∗)},
for all t and m= 0, . . . ,K, where γ∗m(t, lm, am;ψ) is
a known function, smooth in ψ and monotonic in t,
and γ∗m(t, lm, am−1,0;ψ) = 0 for all t, lm, am−1 and
ψ.
5.2 Structural Nested Distribution Models
Structural nested distribution models (SNDMs)
are closely related to SNMMs, but parameterize a
map between percentiles of the distribution of Y am,0k
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and percentiles of the distribution of Y
am−1,0
k . They
are most easily understood by first considering the
class of more restrictive rank-preserving SNDMs. In
particular, for each exposure Am,m = 0, . . . ,K, let
us first consider a rank-preserving SNDM to param-
eterize its effect on the end-of-study outcome Y :
Y am−1,0 = γm(Y
am,0, lm, am;ψ
∗),
for subjects with Am = am and Lm = lm, m = 0,
. . . ,K. Here, γm(y, lm, am;ψ) is a known function,
smooth in ψ and a smooth, monotonic function of
y, which contrasts the counterfactuals Y am−1,0 and
Y am,0, and must satisfy γm(y, lm, am−1,0;ψ) = y for
all y and ψ. For instance, with 2 time points (K =
1) a rank preserving SNDM may be given by the
following set of restrictions:
Y A0,0 = γ1(Y,L1,A1) = Y − (ψ
∗
1 +ψ
∗
2L1)A1,
Y 0 = γ0(Y
A0,0,L0,A0)
= Y A0,0 − (ψ∗1 + ψ
∗
2L0)A0
= Y − ψ∗1(A0 +A1)− ψ
∗
2(L1A1 +L0A0).
A SNDM relaxes these restrictions by demanding
that they merely hold in distribution, conditional on
the observed history (i.e., Lm = lm and Am = am).
To describe the effect on a repeated counterfac-
tual future Y am,0m+1, we can borrow ideas from Sec-
tion 2.3.2. In particular, upon substituting A by
Am, L by Lm,Am−1 and Yk by Y
am,0
m+k in the rank-
preserving model (9), we obtain the identity:
Y
am−1,0
m+k = γm,m+k(Y
am,0
m+1:m+k, lm, am;ψ
∗),(25)
for subjects with Am = am and Lm = lm, m =
0, . . . ,K and k = 1, . . . ,K + 1 − m. Here,
γm,m+k(ym:m+k, lm, am;ψ) is a known function,
smooth in ψ and a smooth, monotonic function of
ym+k, which contrasts the counterfactuals Y
am−1,0
m+k
and Y am,0m+k , and must satisfy γm,m+k(ym:m+k, lm,
am−1,0;ψ) = ym+k for all ym+k, lm, am−1 and ψ. For
instance, with 2 time points (K = 1) a rank pre-
serving SNDM may be given by the following set of
restrictions:
Y 01 = γ0,1(Y1,L0,A0;ψ
∗)
= Y1 − (ψ
∗
1 + ψ
∗
2L0)A0,
(26)
Y A0,02 = γ1,2(Y2,L1,A1;ψ
∗)
= Y2 − (ψ
∗
1 + ψ
∗
2L1)A1,
Y 02 = γ0,2(Y1, Y
A0,0
2 ,L0,A0;ψ
∗)
= Y
(A0,0)
2 − (ψ
∗
3 + ψ
∗
4Y1)A0
(27)
= Y2 − (ψ
∗
1 + ψ
∗
2L1)A1
− (ψ∗3 +ψ
∗
4Y1)A0.
Here, the first two equations express short-term ex-
posure effects, that is, the effect of A0 on Y1 and of
A1 on Y2. The third equation expresses the effect of
A0 on Y2 (more precisely, its effect on Y
A0,0
2 ). As in
Section 2.3.2, this equation must take into account
that the effect may be different depending on the
outcome level at time t1; this allows for A0 to also
affect the dependence between Y1 and Y2, but ev-
idently complicates interpretation. More generally,
rank-preserving SNDMs allow for the effect of am
on Ym+k, as encoded by a contrast of Y
am,0
m+k and
Y
am−1,0
m+k , to depend on the history of treatments and
covariates up to time tm, but additionally on the po-
tential outcome history under the treatment regime
(am,0), up to time tm+k−1.
A SNDM relaxes the restrictions of a rank pre-
serving SNDM by demanding that the equality (25)
merely holds in distribution, conditional on Lm = lm
and Am = am. Assuming that for given (Lm,Am),
Y m+1 has a continuous multivariate distribution
with probability 1, a SNDM can thus be defined by
F
Y
am−1,0
m+1 |Lm=lm,Am=am
{γm(ym+1, lm, am;ψ
∗)}
(28)
= F
Y
am,0
m+1 |Lm=lm,Am=am
(y
m+1
),
for all lm, am, where γm(ym+1, lm, am;ψ
∗) is a vec-
tor with components γm,k(ym+1:m+k, lm, am;ψ
∗) for
k = 1, . . . ,K + 1 −m, where the components γm,k
are defined in recursive fashion similar to in Sec-
tion 2.3.2.
Under the SNDM, a variable Um(ψ
∗) = (Um,m+1(ψ
∗),
. . . ,Um,K+1(ψ
∗))′ can be constructed which predicts
how the outcomes past time tm would look like if
treatment were suspended from time tm onward, in
the sense that
P{Um(ψ
∗)> y
m+1
| Lm,Am = am}
(29)
= P (Y
am−1,0
m+1 > ym+1 | Lm,Am = am).
This variable can be recursively obtained for m =
K, . . . ,0 from
Um,m+k(ψ)
(30)
≡ γm,m+k{(Ym+1,Um+1:m+k(ψ)),Lm,Am;ψ},
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for k = 1, . . . ,K+1−m, where we define Um+1,m+k(ψ)
to be empty for k = 1. For instance, in the SNDM
that assumes the identities in (26) hold in distribu-
tion (conditional on the observed history), we have
that
U1(ψ) = U1,2(ψ) = γ1,2(Y2,L1,A1;ψ)
= Y2 − (ψ1 +ψ2L1)A1,
U0(ψ) = (U0,1(ψ),U0,2(ψ))
= (γ0,1(Y1,L0,A0;ψ),
γ0,2(Y1,U1,2(ψ),L0,A0;ψ))
= (Y1 − (ψ1 + ψ2L0)A0,
Y2 − (ψ1 + ψ2L1)A1 − (ψ3 +ψ4Y1)A0).
The identity (30) will be useful in estimation and
for predicting the effect of specific interventions on
the outcome distribution.
Structural nested failure time models (SNFTMs)
are a variant of SNDMs which have seen most ap-
plications to date. These link percentiles from the
conditional distributions of T am−1,0 and T am,0, con-
ditional on Lm,Am = am, and for subjects who are
still in the risk set (say, alive) at time tm:
S
Tam−1,0|nLm=lm,Am=am,T≥tm
{γm(t, lm, am;ψ
∗)}
= STam,0|Lm=lm,Am=am,T≥tm(t),
for t > tm, where S(·) denotes a survival function.
Here, γm(t, lm, am;ψ
∗) is a known function, smooth
in ψ and monotonic in t, and γm(t, lm, am−1,0;ψ) =
t for all t, lm, am−1 and ψ. For instance, the choice
γm(t, lm, am;ψ) = tm + (t− tm) exp(amψ) for t > tm
expresses that the effect of suspending treatment am
at time tm is to change the residual lifetime t− tm
with a factor exp(amψ). For this choice of model,
one can predict among individuals who survive to
(or through, or until) time tm what their lifetime
would be had treatment been suspended from time
tm onward, as
Um(ψ) = tm +
∑
k:tm≤tk≤T
(tk − tk−1) exp(Akψ)
+ (T − tT−) exp(AtT−ψ),
where tT− denotes the largest time point in {t0, . . . ,
tK} less than T and Um(ψ) is a random variable for
which (for t > tm)
P{Um(ψ
∗)> t | Lm,Am = am, T ≥ tm}
= P (T am−1,0 > t | Lm,Am = am, T ≥ tm).
5.3 Retrospective Blip Models
Retrospective blip models have been extended to
model the effect of a sequential treatment on a scalar
end-of-study outcome Y ≡ YK+1 conditional on the
treatment and covariate history up to end-of-study.
Mean models take the form
g{E(Y am,0 | LK = lK ,AK = aK)}
− g{E(Y am−1,0 | LK = lK ,AK = aK)}(31)
= γ∗m(lK , aK ;ψ
∗),
where γ∗m(lK , aK ;ψ) is a known function, smooth
in ψ and equaling zero for all ψ, lK and aK with
am = 0. Distribution models take the form:
F
Y am−1,0|LK=lK ,AK=aK
{γm(y, lK , aK ;ψ
∗)}
= FY am,0|LK=lK ,AK=aK (y),
where γm(y, lK , aK ;ψ) is a known function, smooth
in ψ and equaling y for all ψ,y, lK and aK with
am = 0; a rank-preserving version of this was pro-
posed by Joffe, Small and Hsu (2007). For nonpara-
metric identifiability, restrictions are needed on the
functions γ∗m(lK , aK ;ψ
∗) and γm(y, lK , aK ;ψ), for
example, that they do not involve the future am+1
and lm+1 (Vansteelandt (2010)).
Retrospective blip models can be useful for model-
ing a dichotomous outcome (Vansteelandt (2010)).
Under these models, identity (24) is satisfied with
U∗m(ψ) being a vector with components
g−1
[
g{E(Y | LK ,AK)} −
K∑
l=m
γ∗l (LK ,AK ;ψ)
]
.
Evaluation of U∗m(ψ) (which is needed to make es-
timation of ψ∗ manageable) then merely requires a
model for E(Y | LK ,AK), but not for the distribu-
tion of treatment and covariates at each time. The
parameters indexing these models are nonetheless
more limited than the parameters indexing SNMMs
in that they cannot be used by themselves for mak-
ing treatment decisions prior to the end-of-study
time, unless one integrates over the distribution of
covariates subsequent to m (see, e.g., Vansteelandt
(2010)).
6. IDENTIFICATION AND ESTIMATION IN
STRUCTURAL NESTED MODELS FOR
SEQUENTIAL TREATMENTS
This section sketches identifying assumptions and
inferential methods for sequential treatments. Under
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instrumental variables assumptions sketched in Sec-
tion 6.3 and under the future ignorability assump-
tions sketched in Section 6.2, inferential methods
have been developed for SNMs, but these assump-
tions do not suffice for the identification of marginal
treatment effects, and hence parameters indexing
MSMs. The broader array of useful identifying as-
sumptions thus constitutes an important advantage
of SNMs.
6.1 Sequential Ignorability
The assumption of ignorable treatment assign-
ment can be generalised to sequential treatments as
follows:
Am ⊥⊥ Y
am−1,0
m+1 | Lm,Am−1 = am−1,(32)
for m = 0, . . . ,K. This assumption has been called
variously “no unmeasured confounders assump-
tion,” “sequential ignorability,” “sequential random-
ization” or “exchangeability.” It expresses that at
each time tm, the observed history of covariates Lm
and exposures Am−1 includes all risk factors of Am
that are also associated with future outcomes.
This assumption together with identity (24) imply
that
E{Um(ψ
∗) | Lm,Am}=E{Um(ψ
∗) | Lm,Am−1}
for all m under a SNMM. The parameter ψ∗ index-
ing a SNMM can therefore be estimated by solving
0 =
n∑
i=1
K∑
m=0
[dm(Lim,Aim)
−E{dm(Lim,Aim) | Lim,Ai,m−1}](33)
× [Uim(ψ)−E{Uim(ψ) | Lim,Ai,m−1}],
where dm(Lim,Aim),m = 0, . . . ,K is an arbitrary
p × (K + 1 −m)-dimensional function, with p the
dimension of ψ. This estimating equation essentially
sets the sum across time points m of the condi-
tional covariances between Uim(ψ) and the given
function dm(Lim,Aim), given Lim,Ai,m−1, to zero.
When the previous outcome is included in the con-
founder history (i.e., Lim includes Yim) and there
is homoscedasticity [i.e., when the conditional vari-
ance of Uim(ψ
∗) given Lim,Aim is constant for m=
0, . . . ,K], then local semiparametric efficiency under
the SNMM is attained upon choosing
dm(Lim,Aim) =E
{
∂Um(ψ
∗)
∂ψ
∣∣∣ Lim,Aim
}
.
Sequential ignorability (32) together with identity
(29) moreover implies that
Um(ψ
∗)⊥⊥Am | Lm,Am−1
for all m under the SNDM. This conditional inde-
pendence restriction suggests that the parameter in-
dexing a SNDM can be solved from
0 =
n∑
i=1
K∑
m=0
dm{Uim(ψ),Aim,Lim}
−E[dm{Uim(ψ),Aim,Lim} | Lim,Aim]
−E(dm{Uim(ψ),Aim,Lim}(34)
−E[dm{Uim(ψ),Aim,Lim} | Lim,Aim] |
Uim(ψ),Lim,Ai,m−1),
where the index functions dm{Uim(ψ),Aim,Lim}
must be of the dimension of ψ. When the previ-
ous outcome is included in the confounder history
(i.e., Lim includes Yim), then local semiparametric
efficiency is obtained upon choosing
dm{Uim(ψ),Aim,Lim}
=E{Sψ(ψ) | Uim(ψ),Aim,Lim},
where Sψ(ψ) is the score for ψ under the observed
data likelihood
f(Y K+1,LK ,AK)
= f{U0(ψ
∗)}
·
K∏
m=0
[
f{Lm | Lm−1,Am−1,Um(ψ
∗)}
× f{Am | Lm,Am−1,Um(ψ
∗)}
·
∣∣∣∣ ∂Um(ψ∗)∂Um+1(ψ∗)
∣∣∣∣
]
,
with all components substituted by suitable para-
metric models (Robins (1997)); here, the term
f{Am | Lm,Am−1,Um(ψ
∗)}= f(Am | Lm,Am−1) un-
der sequential igorability, and thus can be ignored.
This likelihood formulation is of interest in itself
because it enables specifying the joint distribution
of the variables in a way that is consistent with the
sharp null hypothesis of no effect under the assump-
tion of sequential ignorability, even in the presence
of confounding by variables affected by treatment,
which turns out more difficult with standard param-
eterisations (Robins (1997)).
STRUCTURAL NESTED MODELS AND G-ESTIMATION 19
Solving estimating equations (33) and (34) re-
quires a parametric model A for the conditional dis-
tribution of the exposure Am for m= 0, . . . ,K:
f(Am | Lm−1,Am−1) = f(Am | Lm−1,Am−1;α
∗),
where f(Am | Lm−1,Am−1;α) is a known density
function, smooth in α, and α∗ is an unknown finite-
dimensional parameter which can be estimated via
standard maximum likelihood. In addition, it re-
quires a parametric model B for the conditional
mean (or distribution) of U∗m(ψ
∗) [or Um(ψ
∗)] for
m= 0, . . . ,K:
f{Um(ψ
∗) | Lm,Am−1}
= f{Um(ψ
∗) | Lm,Am−1;γ
∗},
where f{Um(ψ
∗) | Lm,Am−1;γ} is a known density
function, smooth in γ and γ∗ is an unknown finite-
dimensional parameter. As before, when the param-
eters α and γ are variation-independent, then so-
called G-estimators that solve (33) and (34), ob-
tained upon substituting α∗ and γ∗ by consistent es-
timators, are doubly robust (Robins and Rotnitzky,
2001): consistent when the SNM and either model
A or model B is correctly specified, regardless of
which. This double robustness property of the G-
estimator is desirable for various reasons. First, it
provides justification for using simple models for the
multivariate distribution f{Um(ψ
∗) | Lm,Am−1} or
even setting E{Uim(ψ) | Lim,Ai,m−1}= 0 in (33) for
computational convenience. Second, while alterna-
tive proposals that rely on correct specification of
model B (see, e.g., Almirall, Ten Have and Murphy
(2010); Henderson, Ansell and Alshibani (2010))
tend to give more efficient estimators (under correct
model specification), the concern for misspecifica-
tion of model B may be considerable in view of the
aforementioned difficulty of postulating this model.
This distribution can indeed be difficult to specify in
view of its multivariate nature, the fact that Um(ψ
∗)
represents a transformation of the observed data
and that it may moreover share the same outcome
over multiple time points, so that the models for
Um(ψ
∗) corresponding to different time points may
not be congenial at all times. This concern can be
overcome by inferring the conditional expectations
E{Um(ψ
∗) | Lm,Am−1} from models for the condi-
tional distribution of Lm+1 given Lm,Am−1 at each
time m (Robins, Rotnitzky and Scharfstein (2000);
Almirall, Ten Have and Murphy (2010)). However,
when the covariate Lm is high-dimensional and/or
strongly associated with treatment Am, specifying
such models can be a thorny and nontrivial task.
6.2 Departures from Sequential Ignorability and
Sensitivity Analysis
Specified departures from (32) can also yield iden-
tification. For instance, one can allow dependence of
treatment on a specified portion of the future poten-
tial outcomes, by relaxing (32) to (Joffe, Yang and
Feldman (2010); Zhang, Joffe and Small (2011))
Am ⊥⊥ Y
am−1,0
m+∆ | Lm,Am−1 = am−1, Y
am−1,0
m+1:m+∆−1,
for some integer ∆≥ 1; such assumptions have been
termed future ignorability, since the independence
at m is conditional on potential outcomes referring
to times after m. This assumption can sometimes
eliminate residual confounding bias, for instance,
because the treatment process occurs in continuous
time but confounding covariates are only measured
intermittently, as is common in observational studies
(Zhang, Joffe and Small (2011)), or when the future
potential outcomes serve as proxies for other unmea-
sured confounding variables (Rosenbaum (1984)).
However, it does not lead to nonparametric iden-
tification of the SNM parameters, so that inference
becomes more dependent on correct specification of
the causal model.
Alternatively, deviations from sequential ignora-
bility can be parameterized as
f(Am = am | Lm = lm,
Am−1 = am−1, Y
am−1,0
m+1 = ym+1)
= t(Am = am | Lm = lm,Am−1 = am−1)
(35)
· exp{qm(ym+1, lm, am)}
·
(∫
t(Am = a
†
m | Lm = lm,Am−1 = am−1)
· exp{qm(ym+1, lm, (am−1, a
†
m))}da
†
m
)−1
,
with qm(·) known, satisfying qm(ym+1, lm, am−1,
am = 0) = 0 for all (ym+1, lm, am−1) and with t(Am |
Lm,Am−1) an unknown conditional density. With
qm(·) = 0 encoding the assumption of sequential ig-
norability, the function qm(·) thus expresses the de-
gree of departure from that assumption. As the data
carry no genuine information about it, progress must
be made by repeating the analysis with qm(·) fixed
at different values, which are then varied over some
plausible range (Robins, Rotnitzky and Scharfstein
(2000)); for example, by setting qm(ym+1, lm, am) =
γym+1am, where γ is varied between −1 and 1.
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6.3 Instrumental Variables Assumptions
When the assumption of sequential ignorability
fails, progress can sometimes be also made using an
instrumental variable (IV). Such variable A0 is as-
sumed to satisfy
A0 ⊥⊥ Y
0 | L0(36)
and
FY 0|L0=l0,A0=a0(y) = FY a0,0|L0=l0,A0=a0(y)(37)
for all a0, l0 (Robins (1989)). Both these assump-
tions together imply that the instrument A0 is not
associated with the outcome, except through its as-
sociation with subsequent treatments Am,m ≥ 1,
which may affect outcome. These or similar as-
sumptions have been used in adjusting for noncom-
pliance in randomized trials (Robins and Tsiatis
(1991); Mark and Robins (1993); Robins (1994)).
With Am,m≥ 1 denoting actual treatment and A0
denoting randomized treatment, these assumptions
are plausible when randomization does not affect the
outcome other than by influencing the actual treat-
ment.
Estimation under the IV assumptions can be
based on estimating equations (33) and (34), but
requires setting dm(Lim,Aim) = 0 and dm{Uim(ψ),
Aim,Lim} = 0 for m > 0. Because of these re-
strictions, root-n estimation of ψ∗ typically re-
quires additional assumptions on γ∗m(lm, am;ψ
∗) and
γm(ym+1, lm, am;ψ
∗). In particular, it is commonly
assumed that these functions are linear in am and
do not involve a0; moreover, time-varying covariates
are commonly ignored, that is, Lm is set empty for
m > 0. For instance, in linear SMMs for a single
treatment A1 (i.e., when K = 1) and dichotomous
instrument, ω(L0) in
E(Y1 − Y
a00
1 | L0 = l0,A1 = a1) = ω(l0)a1,
is just identified. Thus residual dependencies on a0
or nonlinear dependencies on a1 cannot be identified
unless other untestable assumptions are imposed.
The resulting class of G-estimators contains the
popular two-stage least squares estimator as a spe-
cial case (Okui et al. (2012)). However, the frame-
work of G-estimation for SNMMs and SNDMs
has the advantage that it extends immediately to
outcomes that do not lend themselves to linear
modeling, for example, censored failure-time out-
comes (Robins and Tsiatis (1991)) and dichotomous
outcomes (Vansteelandt and Goetghebeur (2003);
Robins and Rotnitzky (2004)), as well as to sequen-
tial treatments (Robins and Hernan, 2009). For in-
stance, when K = 1 and L1 is empty, the logistic
SMM
odds(Y a12 = 1 | L0 = l0,A1 = a1)
odds(Y 02 = 1 | L0 = l0,A1 = a1)
= exp(ψ∗a1),
can be fitted by solving the SMM estimating
equations with U∗(ψ) given by expit{logitE(Y2 |
A1,L0)− ψA1} [cfr. (3)] and E(Y1 | A1,L0) substi-
tuted by the fitted value under a parametric model
(Vansteelandt and Goetghebeur (2003); Vanstee-
landt et al. (2011)). This additional model may
sometimes not be congenial with the SMM and in-
strumental variables assumptions in the sense that
there may be no choice of parameter values index-
ing this model that satisfies these assumptions. This
can be overcome by avoiding parameterization of the
main effect of A0 (conditional on L0) in the model
for E(Y1 |A1,L0) and instead modeling the distribu-
tion of A1, given A0 and L0 (Robins and Rotnitzky
(2004)), or by completely saturating the parameter-
ization of the main effect of A0 (conditional on L0)
(Vansteelandt et al. (2011)). van der Laan, Hubbard
and Jewell (2007) abandon logistic SMMs in favor
of an interesting, but difficult to interpret relative
risk parameterization. Alternatively, multiplicative
SMMs can be used; under such models, case-only es-
timators have been constructed, which remain valid
under case-control sampling (Bowden and Vanstee-
landt (2011)).
Variant assumptions have been proposed that al-
low use of time-varying instruments along with SN-
MMs and G-estimation. Robins and Hernan (2009)
consider settings in which, at each time point, there
is a variable whose association with the outcome of
interest may be explained solely by its association
with prior history and its effect on some treatment
of interest. Joffe, Yang and Feldman (2010) consider
settings in which the conditional independence of
treatment and future potential outcomes in (32)
holds for only an identifiable subset {i,m} of the
person-observations in the population rather than
for all such observations. Treatment assignment in
that subset may thus be considered an instrument
for its effect and the effect of subsequent treatments.
IV analyses have several drawbacks relative to
those based on sequential ignorability: (1) nonpara-
metric identification is lost, and so inference is more
dependent on correct specification of the causal
model; (2) decreased power and precision; and (3)
larger finite-sample bias.
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6.4 Censoring
In SNFTMs, Type I censoring can be dealt with
as previously explained by substituting Um(ψ) by an
arbitrary function of Xm(ψ)≡min{Um(ψ),Cm(ψ)}
and ∆m(ψ)≡ I{Um(ψ)<Cm(ψ)}, where
Cm(ψ)≡min{Um(C,aC , lC ;ψ);aC , lC ∈ LAm(C)},
where LAm(C) is a given set of (aC , lC) histories
which agree with the observed history of L through
time tm or C, whichever comes first, and A through
time tm−1 or C, whichever comes first, and where
Um(C,aC , lC ;ψ) is defined like Um(ψ) in Section 5.2,
but with C replacing T and aC and lC replacing AT
and LT .
7. PREDICTING THE EFFECTS OF
INTERVENTIONS
Identities (24) and (30) suggest using U∗m(ψ
∗)
and Um(ψ
∗), respectively, as a prediction of Y
am−1,0
m+1
among individuals with observed history Am = am.
In particular, E(Y 0 | A0,L0) = E{U
∗
0 (ψ
∗) | A0,L0}
in SNMMs and E(Y 0 |A0,L0) =E{U0(ψ
∗) |A0,L0}
in SNDMs, so that the expected outcome in the ab-
sence of treatment can be estimated as the sam-
ple average of U∗0 (ψˆ) in SNMMs and of U0(ψˆ) in
SNDMs. To estimate E(Y aK ) for a different treat-
ment regime aK , one could use a different structural
nested model (SNM) with aK as the reference treat-
ment regime. However, when—as often—the interest
lies in comparing the expected counterfactual out-
comes between different treatment regimes, then a
concern is that these different SNMs may fail to im-
ply a coherent model. Further complications arise
when the goal is to evaluate the expected counterfac-
tual outcome following a dynamic treatment regime
whereby the treatment at each time tm is assigned as
a function of the treatment and covariate history up
to that time; that is, for each m, am = g(am−1, lm).
These complications can be overcome by sup-
plementing the SNM with so-called current treat-
ment interaction functions (Robins, Rotnitzky and
Scharfstein (2000)) about which the data carry
no information, but which enable one to trans-
port treatment effects in the treated to population-
averaged treatment effects. For instance, let K = 1
and suppose that a SNMM has been fitted with g(·)
the identity link. For simplicity, we focus here only
on the effect of a nondynamic regime (a0, a1) at an
end-of-study outcome Y = Y2; results for dynamic
treatment regimes are recovered upon making the
substitutions (g0(l0), g1(a0, l1)) for (a0, a1). Two cur-
rent treatment interaction functions can be defined,
one for each sequential treatment:
r∗1(L1, a1)
=E(Y a0a1 − Y a00 |A0 = a0,A1 = a1,L1)
−E(Y a0a1 − Y a00 |A0 = a0,A1 6= a1,L1),
r∗0(L0, a1)
=E(Y a0a1 − Y 0 |A0 = a0,L0)
−E(Y a0a1 − Y 0 |A0 6= a0,L0).
These express how much the effects of subsequent
treatment atm [i.e., a1 and (a0, a1) at times 1 and 0,
resp.] differ between groups that received that level
of treatment at m and those that did not. Under
the SNMM, it is easily deduced from knowledge of
r∗1(L1, a1) and r
∗
0(L0, a1) that E(Y
a0a1 − Y 0 | A0 =
a0,L0) equals
E(Y a0a1 − Y a00 |A0 = a0,L0)
+E(Y a00 − Y 0 |A0 = a0,L0)
=E{γ∗1(L1, a1;ψ
∗)
− r∗1(L1, a1)P (A1 6= a1 |A0 = a0,L1) |
A0 = a0,L0}
+ γ∗0(L0, a0;ψ
∗).
Because E(Y a0a1 − Y 0 | L0) moreover equals
E(Y a0a1 − Y 0 |A0 = a0,L0)
− r∗0(L0, a1)P (A0 6= a0 | L0),
we thus obtain that E(Y a0a1) = E(Y a0a1 − Y 0) +
E(Y 0) equals
E[E{γ∗1(L1, a1;ψ
∗)
− r∗1(L1, a1)P (A1 6= a1 |A0 = a0,L1) |
A0 = a0,L0}
+ γ∗0(L0, a0;ψ
∗)
− r∗0(L0, a1)P (A0 6= a0 | L0) +U
∗
0 (ψ
∗)].
When there is no current treatment interaction [i.e.,
r∗1(l1, a1) = r
∗
0(l0, a1) = 0 for all a0, a1, l0, l1], we thus
have that
E(Y a0a1)
=E[E{γ∗1(L1, a1;ψ
∗) |A0 = a0,L0}
+ γ∗0(L0, a0;ψ
∗) +U∗0 (ψ
∗)].
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While the components γ∗1(L1, a1;ψ
∗), γ∗0(L0, a0;ψ
∗)
and U∗0 (ψ
∗) can be estimated along the lines de-
scribed in previous sections, a complication is that
a model for the distribution of L1, conditional on
A0,L0, is needed to evaluate this; this can be cum-
bersome when L1 is high-dimensional. This com-
plication is avoided in simple structural models
in which there is no effect modification by post-
treatment variables [i.e., γ∗1(L1, a1) is not a function
of L1] and nondynamic regimes are considered.
The assumption of no current treatment interac-
tion is satisfied under a mild strengthening of se-
quential ignorability such that
Am ⊥⊥ Y
aK
m+1 | Lm,Am−1 = am−1,
for all m and all treatment histories aK . It is like-
wise sometimes satisfied under a mild strengthening
of the instrumental variables assumption (36) such
that for all treatment histories aK :
A0 ⊥⊥ Y
aK | L0,
and a mild strengthening of the structural model
such that, for instance, for binary A1 (0/1):
E(Y a0a1 − Y a0a
†
1 |A1 = a1,A0 = a0,L0)
= γ∗1(a
†
1,L0;ψ
∗)(a1 − a
†
1),
for all a1, a
†
1. Following the instrumental variables
assumptions, Y a00 and Y a01 should then be inde-
pendent of A0, given L0, which respectively implies
that
E{Y − γ∗1(0,L0;ψ
∗)A1 |A0,L0}
=E{Y − γ∗1(0,L0;ψ
∗)A1 | L0},
E{Y − γ∗1(1,L0;ψ
∗)(1−A1) |A0,L0}
=E{Y − γ∗1(1,L0;ψ
∗)(1−A1) | L0}.
It follows from this that γ∗1(0,L0;ψ
∗) = −γ∗1(1,L0;
ψ∗), and thus again that the no current treat-
ment interaction assumption is satisfied (Hernan
and Robins, 2006).
8. DIRECT AND INDIRECT EFFECTS
SNMs parameterize the effects of treatment at
each time with subsequent treatments set to some
reference level. These effects can be viewed as con-
trolled direct effects (Robins and Greenland (1992)),
controlling all subsequent treatments at their refer-
ence levels. The formalism of SNMs is therefore more
widely applicable for inferring the controlled direct
effect of some target exposure A0 on an outcome Y ,
other than through some mediator A1 (e.g., the di-
rect effect of the FTO gene on the risk of myocardial
infarction other than via body mass). In particular,
in the SNMM
E(Y − Y a00 |A1 = a1,L1) = γ
∗
1(a1,L1;ψ
∗),
E(Y a00 − Y 0 |A0 = a0,L0) = γ
∗
0(a0,L0;ψ
∗),
γ∗0(a0,L0;ψ
∗) encodes the controlled direct effect of
setting A0 to zero, controlling A1 at zero uniformly
in the population. However, caution is warranted be-
cause γ∗0(a0,L0;ψ
∗) may not encode the controlled
direct effect of setting A0 to zero, when controlling
A1 at some value a1 6= 0 (Robins and Wasserman
(1997)). From knowledge that γ∗0(a0, l0;ψ
∗) for all
a0, l0, one thus cannot deduce that A0 has no direct
effect on Y (other than via A1). Robins (1999) there-
fore proposed directly parameterizing the controlled
direct effect as
E(Y a0a1 − Y 0a1 |A0 = a0,L0)
(38)
=m(a0, a1,L0;ψ
∗),
where m(a0, a1,L0;ψ) is a known function, smooth
in ψ, which satisfies m(0, a1, l0;ψ) = 0. In contrast
to SNMMs, (38) parameterizes only the effect of a0;
in (38), a1 may, however, be a modifier of the effect
of a0.
Since model (38) for fixed a1 is a SMM for the
counterfactual outcome Y a1 , the techniques of Sec-
tion 3 would be applicable to estimate ψ∗ if Y a1 were
observed for each subject. Since Y a1 is only observed
for individuals with exposure level a1, Robins (1999)
proposed treating subjects who receive a level of A1
other than a1 as censored and, assuming sequen-
tial ignorability, to inversely weight the data by the
density f(A1 | A0,L1) to control resulting selection
bias. This amounts to solving ψ from an estimating
equation of the form
0 =
1
n
n∑
i=1
1
f(Ai1 |Ai0,Li1)
[d(Ai0,Li0)
−E{d(Ai0,Li0) | Li0}]
(39)
× [Yi −m(Ai1,Li0;ψ)
−E{Yi −m(Ai1,Li0;ψ) | Li0}],
where d(Ai0,Li0) is an arbitrary index function.
More efficient and doubly robust estimators have
been reported elsewhere (Goetgeluk, Vansteelandt
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and Goetghebeur (2008)), as well as extensions to
time-varying treatments (Robins (1999)).
Ignorability assumptions can be violated even in
randomized trials (and Mendelian randomization
studies), where assumption (36) is guaranteed by
design, but the processes underlying the evolution
of subsequent mediators may be poorly understood.
Robins and Greenland (1994) avoid ignorability as-
sumptions concerning the mediators by using ini-
tial randomization (or more generally, instrumental
variables assumptions) to estimate controlled direct
effects with SNFTMs. One can also use these ap-
proaches with SNMMs or SNDMs (e.g., Ten Have
et al. (2007)) and, in principle, in the presence of
multiple mediators.
SMMs have also been developed for so-called nat-
ural direct effects (Robins and Greenland (1992);
Pearl (2001)). With Y a0A
0
1 denoting the counterfac-
tual outcome if A0 were set to a0 and A1 to the
counterfactual level A01 that A1 would take if A0
were set to zero, these are defined by contrasts be-
tween Y a0A
0
1 and Y 0A
0
1 for some a0 6= 0. Because A
0
1
may often reflect a natural level of A1 (as in the ab-
sence of treatment) which differs between subjects,
natural direct effects may have a more appealing
interpretation than controlled direct effects. They
moreover correspond with a measure of natural in-
direct effect in terms of contrasts between Y a0A
a0
1
and Y a0A
0
1 for some a0 6= 0. SMMs for natural direct
effects have been considered van der Laan and Pe-
tersen (2008) and Tchetgen Tchetgen and Shpitser
(2011). Such models are defined by
E(Y a0A
0
1 − Y 0A
0
1 |A0 = a0,L0 = l0)
(40)
=m(a0, l0;ψ
∗),
for each a0, l0, where m(a0,L0;ψ) is a known func-
tion, smooth in ψ, which satisfies m(0,L0;ψ) = 0.
Extensions to sequential treatments or mediators
have so far not been developed in view of difficulties
of identification in such settings.
9. CONCLUDING REMARKS
Structural nested models were designed in part to
deal with confounding by variables affected by treat-
ment. These models maintain close resemblance to
ordinary regression models by parameterizing con-
ditional treatment effects. However, in contrast to
these, they avoid conditioning on post-treatment
variables by modeling the outcome at each time
conditional on the treatment and covariate history
up to that time; they do this after having removed
the effects of later treatments so as to disentangle
the unique contributions of each treatment at each
time. The associated method of G-estimation has
close resemblance to ordinary regression methods
because it realizes control for measured confounders
through conditioning. In spite of these strong con-
nections with popular estimation methods, SNMs
and G-estimation have not become quite as popular
as MSMs and the associated IPW methods (Robins,
Hernan and Brumback, 2000).
The lack of popularity of G-estimation is largely
related to the fact that it cannot usually be per-
formed via off-the-shelf software; however, note that
SAS and Stata macros for SNFTMs and SNCFTMs
are available at http://www.hsph.harvard.edu/
causal/software/. This lack of popularity is ad-
ditionally related to difficulties in solving the esti-
mating equations in the analysis of censored survival
times using SNFTMs. These difficulties can now be
overcome by using the newer class of SNCFTMs
instead (Picciotto et al., 2012; Martinussen et al.
(2011)).
In spite of these limitations, SNMs and G-estimation
allow for greater flexibility than MSMs and typically
yield better performing estimators (see Section 4.1).
This is especially so when handling continuous ex-
posures or when handling a binary exposure that
is strongly correlated with subject characteristics
(e.g., when the treated and untreated are very dif-
ferent in terms of subject characteristics). In the
latter case, IPW estimators will typically have a
poor performance, reflecting the lack of information
about the treatment effect in strata where most/all
subjects are treated or untreated. In contrast, be-
cause SNMs parameterize treatment effects condi-
tionally on covariates, nonsaturated models allow
for borrowing of information, so that G-estimators
can pool the treatment effects across strata, as in
expression (23), downweighing those strata where
information on treatment effect is lacking. SNMs
can also incorporate effect modification by time-
varying covariates. As such, a saturated SNM en-
codes all possible causal contrasts on the consid-
ered scale, in contrast to MSMs which average the
effects across (time-varying) covariates, thereby di-
luting the effects when effect heterogeneity exists on
the considered scale. SNMs can moreover make use
of instrumental variables.
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G-estimation is not to be confused with G-
computation (Robins (1986)), which involves stan-
dardizing the predictions from an outcome model
corresponding to the considered treatment regime,
relative to the confounder distribution in the pop-
ulation. Up to recently, also this approach has re-
ceived little attention in practice because it is com-
putationally intensive and because correct specifica-
tion of models for the distribution of the (possibly
high-dimensional) confounders can be a thorny is-
sue in practice. These concerns, which also relate to
likelihood-based inference under SNDMs (Robins,
Rotnitzky and Scharfstein (2000)), can be some-
what mitigated by summarising the confounders at
each time by a longitudinal propensity score de-
fined as the probability of treatment at that time,
given the history of confounders at that time (Achy-
Brou, Frangakis and Griswold (2010)). However,
this may demand correct specification of propensity
score models in addition to a model for the out-
come at each time. G-computation moreover does
not enable a transparent parameterization of the ef-
fect of a particular treatment regime on the outcome
and may thereby imply a null paradox (Robins and
Wasserman, 1997) according to which tests of the
null hypothesis of no effect may be guaranteed to
reject in large samples (Robins (1997)). However,
recent empirical applications have turned out to be
rather successful (Cain et al. (2011)).
We have attempted to make the literature on
structural nested models and G-estimation more ac-
cessible, while also giving pointers to the related lit-
eratures on effect modification and mediation. Vari-
ants of SNMs have also been developed to help iden-
tify optimal sequences of treatments when treat-
ments may be assigned dynamically as a function
of previous treatment and covariate history. In such
settings, it is more natural to model the effect of a
blip of treatment at m on a particular utility func-
tion Y , such as the outcome at the end-of-study
time, if all subsequent treatments are optimal; that
is, ak = a
opt
k (lk, ak−1) for k > m. This can be done
by parameterizing the so-called regrets: contrasts
of E(Y am,a
opt
m+1 | Lm,Am = am) and E(Y
am−1,a
opt
m |
Lm,Am = am) (Murphy (2003)). Alternatively, since
the optimal treatment is unknown, it may be eas-
ier to parameterize the effect of a blip of treat-
ment at m relative to no treatment when all future
treatments are optimal. This amounts to contrasting
E(Y am,a
opt
m+1 | Lm,Am = am) and E(Y
am−1,0,a
opt
m+1 |
Lm,Am = am) (Robins (2004)). We refer the reader
to other papers in this issue for detailed accounts of
such models. We conclude by expressing our hope
that efforts will be continued to develop computa-
tional algorithms and corresponding software pro-
grams for SNMs, so as to make these methods ac-
cessible to a wider audience.
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